Clinical trial
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis…
NCT00369629 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00369629 |
|---|---|
| Title | Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome |
| Official title | Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients With Advanced Cutaneous T-Cell Lymphoma |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | Gemcitabine, Pemetrexed |
| Enrollment | 14 |
| Start date | Aug 28, 2006 |
| Primary completion | Jul 16, 2012 |
| Completion | Jun 4, 2013 |
| First posted | Aug 29, 2006 |
| Last update posted | Aug 28, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: